Irmgard Hofmann

992 total citations
8 papers, 745 citations indexed

About

Irmgard Hofmann is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Irmgard Hofmann has authored 8 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Irmgard Hofmann's work include Cellular transport and secretion (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Glycosylation and Glycoproteins Research (1 paper). Irmgard Hofmann is often cited by papers focused on Cellular transport and secretion (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Glycosylation and Glycoproteins Research (1 paper). Irmgard Hofmann collaborates with scholars based in Switzerland, United Kingdom and United States. Irmgard Hofmann's co-authors include Sean Munro, Sauveur-Michel Maira, Saskia M. Brachmann, Christian Schnell, Carlos Garcı́a-Echeverrı́a, Christine Fritsch, Shaowen Wang, Susan Wee, Heidi A. Lane and Anne Kienitz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Oncogene.

In The Last Decade

Irmgard Hofmann

8 papers receiving 734 citations

Peers

Countries citing papers authored by Irmgard Hofmann

Since Specialization

Citations

This map shows the geographic impact of Irmgard Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irmgard Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irmgard Hofmann more than expected).

Fields of papers citing papers by Irmgard Hofmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irmgard Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irmgard Hofmann. The network helps show where Irmgard Hofmann may publish in the future.

Co-authorship network of co-authors of Irmgard Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of Irmgard Hofmann. A scholar is included among the top collaborators of Irmgard Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irmgard Hofmann. Irmgard Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Automated ELISA for potency measurements of therapeutic antibodies and antibody fragments 2024 ·Journal of Pharmaceutical and Biomedical Analysis ·Guillaume Rey, (unknown), (unknown), (unknown), Markus W. Wendeler, Irmgard Hofmann, (unknown), Petr Obrdlik	1
2	Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition 2022 ·Journal of Pharmacology and Experimental Therapeutics ·Irmgard Hofmann, Anke Baum, Marco H. Hofmann, Francesca Trapani, (unknown), (unknown), Martin Aichinger, Florian Ebner, (unknown), Norbert Schweifer, Martina M. Sykora, Erik Depla, (unknown), Andreas R. Gschwind, Norbert Kraut, Frank Hilberg, Klaus‐Peter Künkele	9
3	Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO system 2015 ·Biotechnology and Bioengineering ·Irmgard Hofmann, Yingxia Wen, Claudio Ciferri, (unknown), Viola Fühner, Megan Leong, (unknown), (unknown), (unknown), Anders Lilja, Andrea Carfı́, Holger Laux	30
4	K-RAS Mutant Pancreatic Tumors Show Higher Sensitivity to MEK than to PI3K Inhibition In Vivo 2012 ·PLoS ONE ·Irmgard Hofmann, Andreas Weiss, Gaëlle Elain, Maria Schwaederlé, Dario Sterker, Vincent Romanet, Tobias Schmelzle, Albert Lai, Saskia M. Brachmann, Mohamed Bentires‐Alj, Thomas M. Roberts, William R. Sellers, Francesco Hofmann, Sauveur-Michel Maira	58
5	Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells 2009 ·Proceedings of the National Academy of Sciences ·Saskia M. Brachmann, Irmgard Hofmann, Christian Schnell, Christine Fritsch, Susan Wee, Heidi A. Lane, Shaowen Wang, Carlos Garcı́a-Echeverrı́a, Sauveur-Michel Maira	241
6	The Arl4 Family of Small G Proteins Can Recruit the Cytohesin Arf6 Exchange Factors to the Plasma Membrane 2007 ·Current Biology ·Irmgard Hofmann, Amanda L. Thompson, Christopher M. Sanderson, Sean Munro	99
7	An N-terminally acetylated Arf-like GTPase is localised to lysosomes and affects their motility 2006 ·Journal of Cell Science ·Irmgard Hofmann, Sean Munro	177
8	Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy 2004 ·Oncogene ·Celia Vogel, Anne Kienitz, Irmgard Hofmann, Rolf Müller, Holger Bastians	130

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact